Protagonist Therapeutics Virtual KOL Event following ASH
Please join Protagonist Therapeutics management for a Virtual KOL Event following the presentation of PTG-300 data in Polycythemia Vera at the ASH Annual Meeting.
Date: Wednesday, December 9th
Time: 8:30-9:30am ET
Dial-In Details: 1-844-515-9178 (U.S./Canada), 1-614-999-9313 (International) and refer to Conference ID number 8794865. A live and archived webcast will also be accessible in the Investors section of the Company’s website at www.protagonist-inc.com
Featured KOL Speaker: Andrew Kuykendall, M.D., PTG-300 study investigator and member of the Department of Malignant Hematology at the Moffitt Cancer Center
Additional information on Protagonist’s oral and poster presentations at ASH can be found here.